Business, energy, technology, markets and global industry news from Business News Today

pharmaceutical research

PharmaDeviceNews pharmaceutical research
Representative image of pharmaceutical executives and scientists reviewing drug discovery data in a modern research setting, reflecting Eli Lilly and Haisco Pharmaceutical’s multi-program collaboration and the growing role of China-originated innovation in global pharma licensing.
Pharma & Biotech

Can Eli Lilly’s $3bn Haisco deal deepen big pharma’s China drug discovery pipeline?

Eli Lilly’s Haisco deal could be worth over $3 billion. Find out why China-originated drug discovery is becoming harder to ignore.

Read More
Representative image: AI-assisted biopharma research is becoming a bigger focus for drug developers as AstraZeneca licenses Owkin’s AI Scientist platform to support faster analysis of molecular targets, biomarkers, and novel therapeutic opportunities.
Pharma & Biotech

How AstraZeneca’s Owkin deal could push agentic AI deeper into drug development

Pharma has too much data and too little time. AstraZeneca’s Owkin deal tests whether agentic AI can sharpen drug development decisions.

Read More